All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits (vol 128, pg 638, 2022)

BRITISH JOURNAL OF CANCER(2023)

引用 0|浏览14
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要